KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Streptococcus spp. (group C)

• Streptococcus spp.
• Streptococcus spp. (clindamycin-resistant)
• Streptococcus spp. (clindamycin-susceptible)
• Streptococcus spp. (erythromycin-intermediate-susceptible)
• Streptococcus spp. (erythromycin-resistant)
• Streptococcus spp. (erythromycin-susceptible)
• Streptococcus spp. (group C)
• Streptococcus spp. (group D)
• Streptococcus spp. (group F)
• Streptococcus spp. (group G)
• Streptococcus spp. (North America)
• Streptococcus spp. (serogroup A)
• Streptococcus spp. (serogroup B)
• Streptococcus spp. (serogroup C)
• Streptococcus spp. (serogroup C, F,and G)
• Streptococcus spp. (serogroup F)
• Streptococcus spp. (serogroup G)
• Streptococcus spp. (Viridans group)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8